Thus, either HK1 or HK2 overexpression in tumors is thought to provide both a metabolic benefit and an anti-apoptotic capacity that give the cancer cells a growth advantage and increase their resistance to anticancer therapy. This evidence concerns the gene HK2 and cancer.